Psoriasis Triggers You Should Know: The Complete Research-Based Guide to Avoiding Flares

Ask ten people with psoriasis what makes their condition worse, and you will get ten different answers — stress for one, winter cold for another, a glass of wine for a third, a new blood pressure medication for a fourth. This is not coincidence or imagination. It is a reflection of one of psoriasis's most defining characteristics: it is a trigger-sensitive disease, and triggers are deeply personal.

Understanding your triggers is not a passive exercise. It is one of the most powerful things a person with psoriasis can do — because while you cannot change your genetics or permanently reset your immune system with current treatments, you can identify and manage the environmental and lifestyle inputs that turn your genetic predisposition into active, visible disease. This article covers every known psoriasis trigger with the science behind each one, the specific Indian context where relevant, and practical, actionable steps to reduce their impact on your skin.

How Psoriasis Triggers Work: The Biological Mechanism

Before examining individual triggers, it is worth understanding why triggers exist at all — why someone can live with psoriasis-susceptibility genes for years without a flare, and then one difficult month at work or one streptococcal throat infection sends their skin into a severe episode. The answer lies in how psoriasis sits at the intersection of genetic predisposition and immune activation.

The Threshold Model of Psoriasis Flares

People with psoriasis have an immune system that is genetically primed to overreact to certain signals. But that overreaction does not occur constantly — it requires an activating input to push the system past a threshold. Think of the immune system in a psoriasis patient as a spring compressed near its limit: it is under greater baseline tension than average, so it takes less force to release it. Triggers are that force.

The threshold varies between individuals and — in the same individual — over time. When disease is well-controlled and lifestyle factors are optimised, the threshold is higher: more force is needed to trigger a flare. When multiple triggers stack — stress at work coinciding with a winter cold coinciding with a course of antibiotics — the threshold is lowered dramatically, and a severe flare can follow even without any single trigger being dominant. This stacking effect explains why psoriasis flares seem to 'come out of nowhere' during difficult periods of life: multiple smaller triggers have accumulated past the threshold simultaneously.

The Role of Cytokines in Trigger Response

At the molecular level, most psoriasis triggers work by activating the same inflammatory pathways that drive the condition: they promote the release of pro-inflammatory cytokines — particularly TNF-alpha, IL-17, and IL-23 — either by activating T-cells directly, stimulating skin barrier disruption that recruits immune cells, or suppressing the regulatory T-cells that normally keep inflammation in check. Understanding this common mechanism explains why such seemingly different triggers — psychological stress and a skin injury and a medication — can all produce the same end result: a psoriasis flare.

The 13 major categories of psoriasis triggers covered in this guide:   1.  Psychological stress                    2.  Skin injury (Koebner phenomenon)        3.  Streptococcal and other infections     4.  Medications                            5.  Weather and seasonal changes           6.  Sunburn and UV overexposure            7.  Skin care products and irritants 8.  Alcohol consumption 9.  Tobacco smoking 10.  Diet and gut dysbiosis 11.  Hormonal changes 12.  Obesity and metabolic factors 13.  Sleep deprivation

Trigger 1: Psychological Stress — The Most Powerful and Most Personal

Stress is the most consistently identified psoriasis trigger across every published study, every patient survey, and every clinical population worldwide. Between 44% and 88% of people with psoriasis report that psychological stress either precedes new flares, worsens existing disease, or both. It is not merely the most common trigger — it is also the one that creates the most vicious cycle, because psoriasis itself generates stress, and that stress then worsens the psoriasis.

The Science: How Stress Activates Psoriasis

Psychological stress activates the body's stress response systems — particularly the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system. The HPA axis releases cortisol, while the sympathetic nervous system releases catecholamines (adrenaline and noradrenaline). In people without psoriasis, these hormones mount an adaptive stress response and then return to baseline. In psoriasis patients, they trigger a cascade of immune changes that amplify the Th1 and Th17 pathways driving psoriatic inflammation.

Cortisol, paradoxically, is anti-inflammatory at moderate doses — but chronic psychological stress causes glucocorticoid resistance, meaning the immune system becomes desensitised to cortisol's regulatory effects and continues to produce inflammatory cytokines unchecked. Simultaneously, stress hormones stimulate mast cells in the skin to release substance P and other neuropeptides that directly activate the psoriatic immune cascade. This is the biological mechanism behind the clinical observation — confirmed in prospective studies including Verhoeven et al. (2009) — that stress events in psoriasis patients are reliably followed by disease worsening within days to weeks.

Stress in the Indian Context

India's urban working population faces a specific constellation of chronic stressors — long commutes, high-pressure workplaces, financial anxieties, family obligations, and the psychosocial burden of managing a stigmatised chronic illness in a culture where mental health care seeking remains limited. These ambient stressors create a chronically elevated baseline inflammatory state in many psoriasis patients that makes them more vulnerable to flares from additional triggers. The occupational stress of festival seasons, examination periods for students, and family events — weddings, particularly — are reported by Indian psoriasis patients as some of their most consistent flare triggers.

What You Can Do

Managing stress in psoriasis is not optional self-care — it is primary therapy. Mindfulness-Based Stress Reduction (MBSR) has been demonstrated in randomised controlled trials to accelerate psoriasis clearance during phototherapy and to improve long-term disease control. Regular aerobic exercise reduces cortisol and promotes anti-inflammatory cytokine profiles. Yoga — particularly its combination of physical movement, controlled breathing, and meditation — is uniquely well-suited to the Indian context and has documented benefits in inflammatory conditions including psoriasis. Cognitive behavioural therapy (CBT) for psoriasis-related distress is available from clinical psychologists in major Indian cities and is highly effective when accessible.

Trigger 2: Skin Injury — The Koebner Phenomenon

Any physical trauma to healthy skin can trigger new psoriasis plaques at the exact site of injury — a phenomenon first described in 1876 by German dermatologist Heinrich Koebner and now known as the Koebner (or isomorphic) response. It is one of the most clinically distinctive features of psoriasis and affects approximately 25% of patients, with frequency correlating closely with disease activity — the more active the psoriasis, the more likely an injury will trigger new lesions.

What Counts as a Skin Injury?

The range of injuries capable of triggering a Koebner response is wider than most patients realise. Cuts, scratches, surgical incisions, insect bites, friction from clothing (particularly waistbands, bra straps, and tight collars), sunburn, chemical burns, contact dermatitis reactions, tattoos, piercings, acupuncture needles, and vaccinations have all been documented as Koebner triggers. Even aggressive scratching of existing psoriasis plaques can trigger new lesions in adjacent normal skin through the same mechanism.

The timing of the Koebner response is typically 10–20 days after the injury — fast enough to be clearly connected to the triggering event, slow enough to be sometimes overlooked. Plaques that develop through the Koebner phenomenon are clinically indistinguishable from spontaneously occurring plaques and respond to the same treatments. The Koebner phenomenon also explains why psoriasis plaques tend to develop preferentially at friction-prone sites — the elbows, knees, waistline, and scalp — rather than at anatomically random locations.

The Reverse Koebner: When Injury Can Help

In a minority of psoriasis patients, a paradoxical anti-Koebner effect has been observed — in which skin injury in a previously affected area produces resolution of plaques rather than new ones. This reverse Koebner response is poorly understood but may involve the wound-healing response producing immune regulatory signals that suppress local psoriatic inflammation. It has been reported in clinical cases involving superficial dermabrasion and certain laser treatments. While this finding is not yet clinically applicable, it illustrates the complex, site-specific nature of the immune response in psoriasis.

What You Can Do

Protecting the skin from unnecessary injury is a practical daily priority for people with psoriasis. Wearing protective clothing during physical work, using sharp razors rather than blunt ones (to minimise skin trauma during shaving), avoiding tight or rough-textured clothing, treating insect bites promptly to prevent scratching trauma, and managing existing plaques without aggressive scratching or picking are all meaningful protective measures. Think carefully before getting tattoos or piercings during periods of active disease.

Trigger 3: Infections — Streptococcus and Beyond

Infections are among the most clearly documented environmental causes of psoriasis onset and flare. The relationship is most firmly established with streptococcal infections, but a range of other pathogens have also been implicated as psoriasis triggers through well-characterised immune mechanisms.

Streptococcal Throat Infections

Group A beta-haemolytic Streptococcus (GAS) — most commonly presenting as strep throat (pharyngitis), tonsillitis, or perianal streptococcal dermatitis in children — is the most well-established infectious trigger for psoriasis. Guttate psoriasis — characterised by small, widespread teardrop-shaped spots appearing 2–3 weeks after infection — is almost exclusively triggered by streptococcal infection, particularly in children and young adults. In many cases, guttate psoriasis represents the first presentation of psoriasis in a previously unaffected individual.

The mechanism involves molecular mimicry: streptococcal proteins (particularly M-protein and streptococcal pyrogenic exotoxins) share structural similarities with certain human keratinocyte proteins. When the immune system mounts a response against streptococcal antigens, T-cells primed against these bacterial proteins cross-react with skin proteins — triggering the psoriatic inflammatory cascade as collateral damage. People who carry HLA-Cw6 (the most significant psoriasis genetic risk variant) are particularly susceptible to streptococcal triggering of psoriasis.

Recurrent Tonsillitis and Chronic Streptococcal Carriage

In patients with recurrent psoriasis flares clearly linked to recurrent streptococcal tonsillitis, tonsillectomy has been documented to produce significant improvement in psoriasis — occasionally complete remission — in studies from Sweden, Japan, and India. A 2019 systematic review found that tonsillectomy produced clinically meaningful psoriasis improvement in approximately 65% of patients in whom clear tonsillitis-psoriasis links existed. This is not a recommended routine intervention, but it illustrates the importance of identifying and treating chronic streptococcal carriage in psoriasis patients with recurrent guttate or plaque flares.

Other Infections

HIV infection is associated with a paradoxical and often severe worsening of psoriasis — the immune reconstitution triggered by antiretroviral therapy can precipitate dramatic psoriasis flares in HIV-positive patients who develop psoriasis. Staphylococcus aureus colonisation of psoriatic skin amplifies local inflammation and can worsen existing plaques. Candida infections of skin folds can trigger inverse psoriasis flares. Respiratory viral infections — influenza, rhinovirus — are reported by many patients as non-specific flare triggers, likely through the systemic cytokine release of viral infection activating the psoriatic immune pathway.

What You Can Do

Treat throat infections promptly and seek medical attention rather than waiting for them to resolve spontaneously — particularly if you have a history of streptococcal-triggered psoriasis flares. Maintain good oral hygiene to reduce the reservoir of streptococcal bacteria. If you experience recurrent tonsillitis clearly linked to psoriasis flares, discuss this pattern explicitly with both your dermatologist and an ENT specialist, as tonsillectomy may be a meaningful option. Practice standard infection prevention (handwashing, avoiding close contact during illness, up-to-date vaccinations) to reduce overall infectious trigger burden.

Trigger 4: Medications — When Treatment Causes a Flare

A number of commonly prescribed medications are well-documented triggers of new psoriasis onset or worsening of existing disease. Awareness of these drug-psoriasis interactions is essential for both patients and prescribers — especially since many of the culprit medications are used for conditions that are themselves more common in psoriasis patients.

Oral Corticosteroids: The Rebound Trigger

Of all medication triggers, oral corticosteroids deserve the most urgent attention because their withdrawal — particularly when abrupt — can trigger severe, sometimes life-threatening psoriasis flares. When a psoriasis patient takes oral prednisone or dexamethasone for any reason, the drug suppresses the immune pathways driving psoriasis. When discontinued, those pathways 'rebound' with greater activity than before — often producing generalised pustular psoriasis or erythrodermic psoriasis that is dramatically worse than the original presentation. This is why dermatologists consistently advise against using oral corticosteroids for psoriasis management and why any psoriasis patient prescribed oral steroids for another condition should be carefully monitored and tapered off slowly.

Lithium

Lithium carbonate — a first-line mood stabiliser for bipolar disorder — is one of the most firmly established medication triggers for psoriasis. It both induces new-onset psoriasis and worsens existing disease in a dose-dependent manner. The mechanism involves lithium's inhibition of inositol monophosphatase (a second-messenger enzyme in keratinocytes), which promotes keratinocyte proliferation, and its suppression of cyclic AMP — a molecule that normally acts as a brake on T-cell activation. Lithium-induced psoriasis can be particularly treatment-resistant. Patients with bipolar disorder and psoriasis should discuss alternative mood stabiliser options with their psychiatrist.

Beta-Blockers

Beta-blockers — widely prescribed for hypertension, heart failure, arrhythmias, and migraine prevention — are associated with new-onset psoriasis and worsening of existing disease. Propranolol has the strongest evidence as a psoriasis trigger among this class, though other beta-blockers (atenolol, metoprolol) have also been implicated. The mechanism involves beta-adrenergic receptor blockade on immune cells and keratinocytes, altering their response to adrenergic signals in ways that promote inflammation. Given the frequency of cardiovascular comorbidity in psoriasis patients, beta-blocker avoidance is not always possible — but it is worth discussing alternatives with the prescribing clinician.

Antimalarial Drugs

Chloroquine and hydroxychloroquine — used for malaria prophylaxis and prevention, rheumatoid arthritis, and lupus — can trigger or worsen psoriasis, particularly precipitating erythrodermic or pustular flares in susceptible patients. Interestingly, this is particularly relevant in India where malaria prophylaxis with chloroquine remains common. The mechanism is not fully understood but may involve chloroquine's effects on lysosomal function and its interference with antigen presentation. Hydroxychloroquine is generally considered to carry lower psoriasis risk than chloroquine.

NSAIDs and Indomethacin

Non-steroidal anti-inflammatory drugs (NSAIDs) can worsen psoriasis in some patients, with indomethacin having the strongest evidence as a trigger. The mechanism involves inhibition of prostaglandin E2 — a lipid mediator that normally exerts anti-inflammatory effects in skin — resulting in a relative shift toward pro-inflammatory leukotriene production. This effect is not universal, and many psoriasis patients take NSAIDs (including for psoriatic arthritis) without adverse skin effects. However, patients who notice consistent worsening after NSAID use should report this pattern to their doctor.

ACE Inhibitors and Other Medications

ACE inhibitors (used for hypertension and heart failure), interferons (used for hepatitis and multiple sclerosis), terbinafine (an antifungal), and biological agents that block TNF-alpha (paradoxically, in some patients) have all been documented as psoriasis triggers in case reports and small series. The psoriasis community of medications is broader than most prescribers appreciate — any significant worsening of psoriasis shortly after starting a new medication should be reported to a dermatologist and discussed with the prescribing clinician.

Medications most commonly associated with psoriasis onset or worsening:   HIGH RISK:    Oral corticosteroids (especially on withdrawal), lithium, beta-blockers MODERATE:     Chloroquine/hydroxychloroquine, indomethacin, ACE inhibitors LOWER/RARE:   Interferons, terbinafine, certain biologics (paradoxical psoriasis)   Always tell any new prescriber that you have psoriasis before starting a new medication. Never stop prescribed medication without consulting your doctor — always discuss alternatives.

Trigger 5: Weather and Seasonal Changes

Weather is one of the most universally recognised psoriasis triggers — and for the majority of patients, cold and dry conditions are consistently the worst. The seasonal pattern of psoriasis is so well-established that many patients can set their watch by their winter flares and summer improvements. Understanding the specific weather mechanisms involved helps patients prepare and protect themselves rather than being caught off guard by seasonal worsening.

Cold and Dry Weather

Cold, dry air strips moisture from the skin through increased transepidermal water loss (TEWL), compromising the skin barrier. A damaged skin barrier allows irritants and antigens to penetrate more easily, activating local immune responses that initiate or amplify psoriatic inflammation. Cold weather also reduces exposure to natural ultraviolet light — which has documented anti-inflammatory, immunosuppressive effects on psoriatic skin. Combined with indoor heating (which further reduces humidity) and reduced physical activity, winter conditions create a constellation of pro-psoriatic factors that consistently drive seasonal flares for many patients.

In India, northern states — Delhi, Punjab, Haryana, Uttar Pradesh, Himachal Pradesh, Rajasthan in winter — experience cold, dry winters that are particularly challenging for psoriasis patients. The combination of cold temperatures, low humidity, wind exposure, and the indoor heating used in these regions creates conditions that strip the skin of moisture and trigger inflammatory responses. Dermatologists in northern Indian cities consistently report higher rates of psoriasis consultations and flares in winter months.

Hot and Humid Weather: A Double-Edged Sword

For most psoriasis patients, warm and humid weather — and moderate sun exposure — improves skin symptoms significantly. Higher humidity supports skin barrier function, warmth reduces the viscosity of topical treatments (improving penetration), and natural UV light suppresses the overactive T-cells driving psoriatic inflammation through the same mechanism as medical phototherapy. This is why many patients notice dramatic improvement during summer months or after a beach holiday — and why some dermatologists recommend sun exposure as part of a comprehensive management strategy.

However, not all patients improve in hot weather. High temperatures can cause profuse sweating, which irritates psoriatic skin — particularly in inverse psoriasis affecting skin folds. Heat and humidity also increase the risk of secondary fungal infections in moist areas. Extreme heat can sometimes trigger flares through inflammatory vasodilation, particularly in patients with sensitive or already-compromised skin. The key is moderation — warm, moderately humid conditions help; extreme heat and sweating can harm.

Seasonal Transition Periods

For many patients, it is not stable cold or stable warmth that triggers flares — it is the transition between seasons. The rapid change in temperature, humidity, and UV levels during autumn (as summer ends) and early spring (as winter breaks) can destabilise the immune equilibrium many patients achieve in stable seasonal conditions. Preparing skin care routines in advance of seasonal transitions — switching to richer moisturisers before winter arrives, rather than after dryness has already set in — is one of the most practically effective strategies for blunting seasonal trigger impact.

What You Can Do

Use a rich, fragrance-free emollient twice daily throughout winter — not only when skin feels dry. A room humidifier in sleeping areas can significantly reduce the drying effect of indoor heating and has documented benefits for skin barrier function during winter months. Seek moderate sun exposure during milder weather (15–30 minutes of unprotected sun on affected skin, avoiding peak UV hours), while protecting unaffected skin from sunburn. Plan seasonal reviews with your dermatologist — transitioning treatment intensity in anticipation of seasonal trigger periods rather than reacting to established flares.

Trigger 6: Sunburn and UV Overexposure

This trigger deserves its own section because it sits in apparent contradiction with what was said above about sun exposure being beneficial. The key distinction is dose: moderate, controlled UV exposure improves psoriasis; excessive UV exposure causing sunburn worsens it, sometimes severely.

Sunburn is a form of acute skin injury — it triggers the same inflammatory cascade as any physical skin trauma, with the addition of significant UV-induced DNA damage that provokes a robust immune response. In psoriasis patients, this sunburn-triggered inflammation can activate the Koebner response, precipitate a widespread flare, or in severe cases trigger erythrodermic psoriasis. Patients undergoing phototherapy should therefore follow their dermatologist's protocol precisely — the therapeutic window for UV in psoriasis is real and valuable, but overexposure crosses into harm.

Paradoxically, some patients who seek sun exposure as treatment over-expose themselves in their enthusiasm — sitting in direct midday summer sun for extended periods, or using commercial tanning beds without professional guidance. Tanning beds should be avoided without medical advice: they typically use UVA-dominant light, which is not the therapeutically effective wavelength for psoriasis (narrowband UVB at 311–313 nm is the evidence-based choice), and prolonged UVA exposure increases skin cancer risk without meaningful psoriasis benefit.

Trigger 7: Skin Care Products and Contact Irritants

The products applied to psoriatic skin every day — soaps, shampoos, moisturisers, cosmetics, and cleaning agents — can either support the skin barrier and reduce inflammation or disrupt it further and trigger flares. Navigating product safety is a practical daily challenge for people with psoriasis.

Soaps, Detergents, and Cleansers

Standard soaps and many detergent-based body washes are alkaline, with pH values significantly higher than the skin's natural slightly acidic pH (4.5–5.5). Alkaline cleansers disrupt the skin's acid mantle — the thin film of natural secretions that supports the skin's microbiome and barrier function — increasing permeability to irritants and allergens. For people with psoriasis, whose skin barrier is already compromised, alkaline soap use can directly worsen scaling, dryness, and inflammation. pH-balanced, soap-free, fragrance-free cleansers are the safest choice.

Fragrances and Preservatives

Fragrances are among the most common causes of contact dermatitis — and in psoriasis patients, contact dermatitis on psoriatic skin can trigger a Koebner response and worsen plaques significantly. Preservatives including methylisothiazolinone, methylchloroisothiazolinone, and parabens are also frequent sensitisers. Reading ingredient lists and avoiding products containing fragrance (listed as 'parfum' or 'fragrance' on labels) and known preservative sensitisers is important skin protection for psoriasis patients.

Hair Dyes and Scalp Products

Hair dyes — particularly those containing para-phenylenediamine (PPD), the most common hair dye allergen — can trigger severe contact allergic reactions on the scalp, and in psoriasis patients, these reactions can precipitate or dramatically worsen scalp psoriasis flares through the Koebner mechanism. Hair relaxers, perming solutions, and bleaching agents are similarly irritating. For people with active scalp psoriasis, hair colouring is best avoided until the scalp is well-controlled — and if done, performed using patch testing first to rule out PPD allergy.

What to Look for in Psoriasis-Safe Products

The safest products for psoriasis skin are pH-balanced, fragrance-free, alcohol-free (alcohol is drying and irritating), dye-free, and formulated without known sensitisers. For scalp psoriasis specifically, medicated or plant-based therapeutic shampoos — rather than standard commercial shampoos — provide the additional benefit of active ingredients targeting the psoriatic process alongside the cleansing function.

Trigger 8: Alcohol Consumption

Alcohol's relationship with psoriasis is complex, consistent, and — in epidemiological terms — among the strongest modifiable risk factor associations in the entire psoriasis literature. Multiple large population studies have found significantly higher rates of alcohol consumption in psoriasis patients than in matched controls, and a dose-dependent relationship between alcohol intake and psoriasis severity has been demonstrated across multiple cohorts.

How Alcohol Worsens Psoriasis

Alcohol promotes psoriatic inflammation through multiple simultaneous mechanisms. It increases intestinal permeability — allowing bacterial lipopolysaccharides (LPS) to translocate from the gut into the systemic circulation, where they activate innate immune responses and promote TNF-alpha production. It suppresses regulatory T-cell function, removing an important brake on the Th1 and Th17 responses driving psoriasis. It directly activates keratinocyte proliferation through effects on polyamine synthesis. And it is hepatotoxic — damaging the liver in ways that matter particularly in psoriasis patients, since the liver is a key site of immune regulation and the primary organ for metabolising several systemic psoriasis medications.

The clinical implications are significant and practical. Psoriasis patients who drink heavily respond less well to all categories of treatment — topicals, phototherapy, systemic drugs, and biologics. Methotrexate — one of the most widely used and cost-effective systemic treatments in India — carries a risk of liver toxicity that is dramatically amplified by concurrent alcohol use. Patients on methotrexate are advised to abstain from alcohol entirely, not merely to reduce consumption.

What You Can Do

Even moderate reduction in alcohol intake — not necessarily full abstinence — produces measurable improvements in psoriasis control for many patients. For patients whose disease is difficult to control despite adequate treatment, alcohol reduction is one of the first lifestyle modifications a dermatologist should discuss. For patients on methotrexate, full abstinence is not a preference — it is a clinical necessity. For others, working toward minimal or nil alcohol consumption as a long-term goal is one of the highest-impact lifestyle changes available.

Trigger 9: Tobacco Smoking

The relationship between smoking and psoriasis is one of the strongest, most consistent, and most dose-dependent in dermatology. Current smokers have approximately double the risk of developing psoriasis compared to non-smokers, and the risk increases linearly with cigarettes smoked per day and pack-years of smoking history. Among psoriasis subtypes, palmoplantar pustulosis — characterised by recurrent pustules on the palms and soles — is so strongly associated with smoking that some researchers consider tobacco use a near-essential cofactor for this specific subtype.

Mechanisms: Multiple Pathways to Inflammation

Tobacco smoke promotes psoriatic inflammation through several simultaneous mechanisms. Oxidative stress from cigarette smoke directly activates NF-kB — the transcription factor that drives pro-inflammatory cytokine gene expression including TNF-alpha and IL-6. Nicotine and other tobacco compounds produce epigenetic modifications in immune cells that promote pro-inflammatory gene expression. Smoke induces vasoconstriction that reduces skin oxygenation, impairs wound healing, and alters the local immune environment of psoriatic skin. Polycyclic aromatic hydrocarbons in smoke activate the aryl hydrocarbon receptor (AhR) — a pathway that promotes Th17 cell development and IL-17 production.

The Impact on Treatment Response

Smoking does not merely trigger psoriasis — it makes it harder to treat. Studies consistently find that psoriasis patients who smoke achieve lower response rates to all treatment categories, including phototherapy, methotrexate, cyclosporine, and biologic therapies. A 2018 meta-analysis found that smoking was associated with a significantly reduced probability of achieving PASI 75 response to anti-TNF biologic therapy. For patients whose psoriasis is proving difficult to control on apparently adequate treatment, smoking status should always be reviewed — continued smoking may be the primary explanation for treatment resistance.

What You Can Do

Smoking cessation is one of the highest-return lifestyle interventions available to psoriasis patients — with documented improvement in disease severity observed progressively over 12–24 months after quitting. The National Tobacco Cessation Programme in India provides free counselling and pharmacotherapy (nicotine replacement therapy, varenicline) through government hospitals and selected health centres. For patients with palmoplantar pustulosis specifically, smoking cessation can produce near-complete remission in a proportion of cases without any additional medication change.

Trigger 10: Diet and Gut Dysbiosis

The relationship between diet, gut health, and psoriasis has moved from anecdote to active science over the last decade. While no single food definitively causes psoriasis, dietary patterns have measurable effects on the systemic inflammatory burden that sustains psoriatic disease — and gut microbiome disruption (dysbiosis) is increasingly recognised as a meaningful contributor to psoriasis activity.

Foods That Worsen Psoriasis

Dietary patterns associated with worsened psoriasis share a common feature: they promote systemic inflammation. High-glycaemic-index foods (white rice, refined flour products, sugary drinks, processed snacks) promote insulin spikes that stimulate pro-inflammatory cytokine production and directly activate keratinocyte proliferation. Red and processed meat consumption is associated with higher circulating TNF-alpha and IL-6. Trans fats and excessive omega-6 fatty acids (from refined vegetable oils) promote arachidonic acid metabolism toward pro-inflammatory prostaglandins and leukotrienes. For Indian patients specifically, very spicy foods, fried snacks, excessive salt, and maida-based products are commonly reported as personal triggers and align with the broader inflammatory dietary pattern evidence.

The Gut Microbiome Connection

Multiple studies have identified significantly reduced gut microbial diversity and altered microbial composition in people with psoriasis compared to healthy controls. Reductions in beneficial anti-inflammatory bacteria — particularly Faecalibacterium prausnitzii and Akkermansia muciniphila — are consistent findings. These bacteria produce short-chain fatty acids (SCFAs) including butyrate that are essential for gut barrier integrity and for maintaining the immune regulatory environment that keeps Th17 responses in check. Gut dysbiosis — whether from poor diet, antibiotic use, stress, or illness — can therefore amplify the Th17-driven inflammation central to psoriasis.

Gluten Sensitivity and Psoriasis

A proportion of psoriasis patients — estimated at 4–10%, significantly higher than in the general population — have coeliac disease or non-coeliac gluten sensitivity. In this subgroup, gluten ingestion triggers an intestinal immune response that amplifies systemic inflammation and can worsen psoriasis. A gluten-free diet in confirmed gluten-sensitive psoriasis patients has been shown in studies to reduce PASI scores significantly. Testing for anti-gliadin antibodies and anti-tissue transglutaminase antibodies is reasonable in psoriasis patients with gastrointestinal symptoms or a history of iron-deficiency anaemia.

What You Can Do

An anti-inflammatory dietary pattern — the Mediterranean diet is the most evidence-supported model — reduces systemic inflammatory markers and is associated with lower psoriasis severity in multiple studies. For Indian patients, this translates to increasing intake of oily fish (sardines, mackerel, rohu), flaxseeds and walnuts (plant-based omega-3 sources), fresh vegetables including leafy greens, lentils and legumes, turmeric-containing foods, amla, and whole grains — while reducing refined carbohydrates, processed and fried foods, red meat, and sugary beverages. Supporting gut health through dietary fibre, fermented foods (curd, kanji, fermented rice preparations), and minimising unnecessary antibiotic use protects the microbiome diversity that supports immune regulation.

Trigger 11: Hormonal Changes

Hormonal fluctuations influence psoriasis activity throughout life — particularly in women, for whom multiple hormonal transitions (puberty, pregnancy, menstruation, menopause) can each alter disease course significantly. The immune system is profoundly sensitive to sex hormone concentrations, and the same hormonal changes that regulate reproductive function also modulate the Th1/Th17 versus Treg/Th2 balance central to psoriasis.

Pregnancy: Improvement and Postpartum Flares

Many women experience significant improvement in psoriasis during pregnancy — particularly in the second and third trimester. This is attributed to the natural shift toward a Th2-dominant immune profile during pregnancy (which suppresses the Th1 and Th17 responses driving psoriasis) and to elevated levels of oestrogen and progesterone that have direct anti-inflammatory effects on immune cells. Studies find that approximately 55–60% of pregnant women with psoriasis report improvement, 20–25% remain unchanged, and 15–20% worsen during pregnancy.

Postpartum flares are common and can be severe — as the protective hormonal environment of pregnancy withdraws rapidly after delivery, the immune system reconstitutes in a strongly pro-inflammatory direction. Women with moderate-to-severe psoriasis who are planning pregnancy should discuss postpartum flare management strategies with their dermatologist in advance, including which treatments are safe to resume during breastfeeding.

Menstruation and the Menstrual Cycle

A significant proportion of women with psoriasis report cyclical worsening related to their menstrual cycle — most commonly in the premenstrual phase, when oestrogen and progesterone levels drop and pro-inflammatory cytokine activity is less restrained. Keeping a symptom diary that includes menstrual cycle phase is a useful way to identify and document this pattern, which may influence both treatment timing and the discussion of hormonal interventions with a gynaecologist.

Menopause

The oestrogen decline of menopause is associated with increased systemic inflammation, and many women notice worsening psoriasis around perimenopause and after. The pro-inflammatory hormonal environment of menopause — combined with the weight gain and metabolic changes common in this life stage — can significantly increase disease activity. Women entering menopause with psoriasis should have a review of their psoriasis management with their dermatologist, as treatment that was adequate during reproductive years may need intensification.

Triggers 12 and 13: Obesity and Sleep Deprivation

Obesity: A Trigger and an Amplifier

Obesity does not merely coexist with psoriasis — it actively drives it. Adipose (fat) tissue is metabolically active, producing pro-inflammatory adipokines including leptin, resistin, and TNF-alpha that directly amplify the cytokine pathways driving psoriatic plaques. The relationship is dose-dependent: higher BMI correlates with higher PASI scores, poorer treatment response, and lower rates of remission. Particularly relevant for Indian patients — who face high rates of central (abdominal) obesity even at relatively modest overall BMI — is the finding that visceral adiposity is more strongly associated with psoriasis severity than overall body weight, because visceral fat is metabolically more active than subcutaneous fat.

The good news is that the relationship is bidirectional in a helpful direction: weight loss in overweight and obese psoriasis patients consistently improves disease severity, independent of medication change. Clinical trials including the OSLO study have found that structured weight loss programmes produce PASI reductions comparable to adding a second medication — and also improve the response to existing medications. For overweight psoriasis patients whose disease is inadequately controlled, weight management is not merely a healthy lifestyle choice — it is a primary treatment strategy.

Sleep Deprivation: The Overlooked Trigger

Poor sleep is both a consequence and a trigger of psoriasis — and its bidirectional relationship with the condition creates one of the most vicious cycles in psoriasis management. Nocturnal pruritus disrupts sleep, and disrupted sleep elevates cortisol and suppresses regulatory immune function, promoting Th1/Th17 immune activity the following day. Multiple studies have confirmed that objectively measured poor sleep quality — not just subjective sleep dissatisfaction — is independently associated with higher psoriasis activity scores, independent of psychological distress, treatment adequacy, or physical symptom burden.

Addressing sleep in psoriasis requires a two-pronged approach: treating the nocturnal itch that disrupts sleep (effective topicals applied at bedtime, antihistamines when appropriate), and optimising sleep hygiene independently (consistent sleep-wake schedule, cool sleeping environment, minimising blue light exposure before bed, avoiding alcohol which disrupts sleep architecture despite inducing drowsiness). Sleep is not a passive absence of wakefulness — it is an active immunological process, and restoring its quality is a meaningful component of psoriasis management.

Building Your Personal Trigger Profile: A Practical Framework

Knowing the full list of potential psoriasis triggers is useful knowledge. Knowing your personal triggers is what changes your daily life. Every person with psoriasis has a unique trigger profile — a specific combination of inputs that, when present, reliably worsen their disease. Identifying that profile is not complicated, but it does require systematic observation over time.

The Symptom and Trigger Diary

A trigger diary — kept consistently for at least 2–3 months — is the most clinically valuable tool for personal trigger identification. Record daily: skin condition (using a simple 0–10 rating), sleep quality, stress level, dietary intake (with particular attention to potential dietary triggers), alcohol consumption, physical activity, any new medications or supplements, weather conditions, menstrual cycle phase (for women), and any skin injuries or infections. After 2–3 months, patterns become visible — consistent associations between specific inputs and worsening skin — that guide personalised management decisions.

Digital apps designed for chronic disease self-monitoring can simplify this process. The National Psoriasis Foundation (accessible in India through their website) offers a free trigger diary template. Even a simple notes app on a mobile phone, used consistently, generates the kind of longitudinal data that can make a clinical consultation far more productive — and help a dermatologist make management decisions based on your specific trigger profile rather than general population averages.

The Trigger Management Priority List

Not all triggers carry equal weight, and not all are equally modifiable. Prioritising trigger management requires an honest assessment of both impact and controllability. Stress and diet may be major contributors but are controllable with commitment. Medications cannot simply be stopped without medical supervision. Seasonal weather cannot be changed but can be prepared for. The most useful approach is to identify the 2–3 triggers that have the greatest impact on your disease, that are within your capacity to modify, and focus initial management efforts there — adding further trigger management as the first targets are addressed.

Your personal trigger management priority framework:   HIGH IMPACT + CONTROLLABLE:                                   Stress (yoga, mindfulness, CBT)                                Diet (anti-inflammatory food pattern)                                Smoking (cessation programmes)                                Alcohol (reduction/abstinence)                                Weight (structured weight loss)   HIGH IMPACT + MANAGEABLE:                                    Seasonal changes (advance skin prep, humidifier)                                Skin care products (switch to psoriasis-safe range)                                Sleep (treat nocturnal itch, sleep hygiene)   HIGH IMPACT + MEDICAL INPUT:                                 Medications (discuss alternatives with prescribers)                                Infections (prompt treatment, tonsillectomy discussion)                                Hormonal changes (management review at transitions)   MODERATE IMPACT + PROTECTIVE:                                Avoiding skin injury (protective clothing, safe shaving)                                Sensible sun exposure (15–30 min, avoid sunburn)

 

Frequently Asked Questions: Psoriasis Triggers

Q1. What is the most common psoriasis trigger?

Psychological stress is the most consistently reported psoriasis trigger across all patient populations and research studies worldwide, with 44–88% of patients identifying it as a factor in their flares. Stress activates the HPA axis and sympathetic nervous system, producing hormonal and immune changes that directly amplify the Th1/Th17 pathways driving psoriasis. It is also the trigger most embedded in a self-sustaining cycle: psoriasis causes stress, and stress worsens psoriasis.

Q2. Can certain foods trigger psoriasis?

Yes — dietary patterns can measurably worsen psoriasis in susceptible individuals. High-glycaemic-index foods, red and processed meat, refined vegetable oils high in omega-6, alcohol, and highly processed foods are consistently associated with worsened psoriasis severity. For Indian patients, very spicy foods and fried snacks are commonly reported personal triggers. Conversely, anti-inflammatory dietary patterns rich in omega-3 fatty acids, fresh vegetables, and whole grains are associated with reduced disease severity.

Q3. Can stress alone cause a psoriasis flare?

Yes — in people with the genetic predisposition for psoriasis, psychological stress alone can trigger a flare even in the absence of other contributing factors. Stress acts through the HPA axis and sympathetic nervous system to activate the same immune pathways that drive psoriatic plaques. Patients who describe themselves as 'stress responders' — those in whom stress is the primary trigger — have a documented pattern of flares following stressful life events with no other identifiable concurrent trigger.

Q4. Why does my psoriasis flare every winter?

Winter conditions create a constellation of psoriasis-promoting factors: cold air reduces skin hydration through increased transepidermal water loss; indoor heating further reduces humidity; reduced daylight limits beneficial UV exposure; and cold-induced vasoconstriction impairs skin oxygenation and healing. Many patients also experience reduced physical activity and higher stress during winter months, adding further inflammatory burden. Preparing skin with richer emollients before winter arrives — not after dryness has set in — and using indoor humidification can significantly blunt the seasonal trigger effect.

Q5. Can a throat infection trigger psoriasis?

Yes — particularly streptococcal throat infections, which are one of the most firmly established psoriasis triggers. Group A Streptococcus triggers guttate psoriasis (a widespread spotted form) through molecular mimicry — streptococcal proteins structurally resemble skin proteins, causing the immune system to attack both. Guttate episodes following strep throat are often the first presentation of psoriasis in children and young adults. Treating strep infections promptly and thoroughly is an important psoriasis management strategy for susceptible patients.

Q6. Which medications trigger psoriasis flares?

The most significant medication triggers are oral corticosteroids (particularly on withdrawal), lithium (used in bipolar disorder), beta-blockers (used for hypertension and heart disease), antimalarial drugs (chloroquine, hydroxychloroquine), and indomethacin. Less common triggers include ACE inhibitors, interferons, and terbinafine. Always inform any new prescriber of your psoriasis diagnosis before starting a new medication, and never stop prescribed medication without medical advice — always discuss alternatives with your doctor.

Q7. Does alcohol really make psoriasis worse?

Yes — consistently and through multiple biological mechanisms. Alcohol increases intestinal permeability (promoting systemic immune activation), suppresses regulatory T-cell function, directly promotes keratinocyte proliferation, and impairs liver function relevant to psoriasis drug metabolism. Multiple large studies confirm a dose-dependent relationship between alcohol intake and psoriasis severity. Even moderate reduction in drinking produces measurable improvements in disease control for many patients, and full abstinence is clinically required for patients on methotrexate.

Q8. How long after a trigger does a psoriasis flare appear?

Timing varies by trigger type. The Koebner response (skin injury) typically produces new plaques 10–20 days after the injury. Streptococcal infection-triggered guttate psoriasis typically appears 2–3 weeks after the infection. Stress-triggered flares can appear within days to 2 weeks of the stressful event. Medication-triggered flares vary — lithium-induced psoriasis may take months of treatment before appearing; steroid rebound flares typically develop within days of discontinuation. Recording the timing of trigger exposures and skin changes in a diary helps identify which triggers are most relevant for you personally.

Q9. Can smoking really cause psoriasis?

Smoking both triggers psoriasis in people with genetic predisposition and worsens existing disease significantly. Current smokers have approximately double the risk of developing psoriasis compared to non-smokers, and the relationship is dose-dependent — more cigarettes smoked means higher risk. Smoking also makes psoriasis harder to treat: patients who smoke achieve lower response rates to phototherapy, systemic medications, and biologics than non-smokers. Smoking cessation is associated with progressive psoriasis improvement over 12–24 months and is particularly impactful for palmoplantar pustulosis.

Q10. How do I identify my personal psoriasis triggers?

The most effective method is a systematic trigger diary kept over 2–3 months, recording daily skin condition, stress level, diet, sleep quality, alcohol intake, weather, any new medications, skin injuries, and menstrual cycle phase (for women). Consistent patterns — specific inputs reliably followed by worsening skin within days to weeks — identify personal triggers more accurately than any generalised list. A dermatologist can help interpret your diary and prioritise the triggers most worth addressing based on your specific disease pattern.

Sources and References

•       Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet. 2021;397(10281):1301–1315.

•       Boehncke WH, Schön MP. Psoriasis. Lancet. 2015;386(9997):983–994.

•       Verhoeven EWM, et al. Stress and the relapse of psoriasis: results of a prospective study. Br J Dermatol. 2009;160(4):730–736.

•       Fortune DG, et al. Psychological distress impairs clearance of psoriasis in patients treated with phototherapy. Arch Dermatol. 2003;139(6):752–756.

•       Naldi L, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis. J Invest Dermatol. 2005;125(1):61–67.

•       Brenaut E, et al. Alcohol consumption and psoriasis. Eur J Dermatol. 2013;23(6):789–798.

•       Budu-Aggrey A, et al. Evidence of a causal relationship between body mass index and psoriasis. PLOS Med. 2019;16(1):e1002739.

•       Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014;70(3):512–516.

•       Heng YK, et al. Psoriasis in Asian patients. J Eur Acad Dermatol Venereol. 2013;27(5):527–534.

•       Scher JU, Abramson SB. The microbiome and psoriatic disease. J Invest Dermatol. 2011;131(12):2442–2444.

•       Basavaraj KH, et al. Diet in dermatology: present perspectives. Indian J Dermatol. 2010;55(3):205–210.

•       Dogra S, Mahajan R. Psoriasis: epidemiology, clinical features, co-morbidities. Indian Dermatol Online J. 2016;7(6):471–480.

•       Gupta MA, Simpson FC. Psychological comorbidity in dermatologic disorders. Am J Clin Dermatol. 2015;16(4):285–296.

•       Gudjonsson JE, et al. Streptococcal throat infections and exacerbation of chronic plaque psoriasis. Br J Dermatol. 2003;149(3):530–534.

•       Thorleifsdottir RH, et al. Improvement of psoriasis after tonsillectomy is associated with a decrease in the frequency of circulating T cells. J Immunol. 2012;188(12):5962–5969.

•       Hawkes JE, Chan TC, Krueger JG. Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol. 2017;140(3):645–653.

•       Lowes MA, Suárez-Fariñas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014;32:227–255.

•       National Psoriasis Foundation. Triggers. www.psoriasis.org (accessed 2024).

•       World Health Organization. Global Report on Psoriasis. Geneva: WHO; 2016.

•       IADVL Psoriasis Task Force. Indian guidelines for the management of psoriasis. Indian J Dermatol Venereol Leprol. 2020.

 

Last reviewed: June 2026. This article is for informational purposes only and does not substitute for professional medical advice. Always consult a qualified dermatologist for diagnosis and personalised treatment.